Category: Stock Market

The S&P/ASX 200 Index (ASX: XJO) is in the red in Tuesday morning trade, down another 0.54%. If the index keeps tumbling it’ll mark six straight days of declines.

The Australian share market has seen widespread selling across most sectors and weak investor sentiment. The ASX 200 is also reacting to a mixed start in US sharemarkets this week.

The softer market has also seen some ASX 200 shares fall to fresh 52-week lows.

Here are four of them.

Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)

Fisher & Paykel shares are down another 0.24% this morning to a new 52-week low of $29.18 a piece. The slump means the respiratory designer and manufacturer’s share price is now 10% lower for the year-to-date and 9% lower than this time last year. There hasn’t been any price-sentitive news out of the company recently to explain the decline, so it’s most likely the result of a continued sector-side sell off of ASX healthcare shares. TradingView data suggests brokers are still bullish for the ASX 200 company’s shares, with the majority holding a buy or strong buy rating on the stock. Brokers tip an average 20% upside to $34.86 over the next 12 months.

Ansell Ltd (ASX: ANN)

Ansell is another ASX 200 healthcare company which makes gloves and other personal protection equipment. Its shares have also been caught up in the widespread ASX healthcare sell-off. At the time of writing, Ansell shares are down 1.06% to $26.24 a piece, marking a 22-month low. Again, brokers are bullish about the outlook for the ASX 200 company’s shares. Out of 12 analysts, seven have a hold rating and 5 rate the shares a buy or strong buy. Brokers tip an average 34% upside to $35.18 over the next 12 months. Some think the shares can rocket even further. The maximum $40.45 target price implies a potential 54% upside at the time of writing.

Harvey Norman Holdings Ltd (ASX: HVN)

Harvey Norman shares have hit a fresh 52-week low of $4.47 in Tuesday morning trade. The share price has now crashed 36% for the year-to-date after the sell-off accelerated in late-February. The ASX 200 retail giant has faced strong headwinds over the past year on the back of renewed concerns about rising inflation and how it could impact consumer spending. Tighter household budgets mean Australians are spending less on discretionary items this year. At the same time, after a strong rally in mid-late 2025, it looks like investors quickly took their profits off the table in early 2026. TradingView data shows that analysts are relatively divided about the outlook or the shares, with several neutral ratings, but they mostly agree that the shares are now trading below fair value. The average target price on the ASX 200 retail shares is $5.76, which implies another 29% upside at the time of writing. 

Metcash Ltd (ASX: MTS)

Metcash shares have tumbled another 1.42% in morning trade to a new 52-week low of $2.78 a piece. It also represents the lowest point the shares have fallen to in nearly six years. The IGA network owner’s shares have come under pressure following an underwhelming FY26 half-year result in December last year. It continues to face headwinds amid a tough retail environment and dwindling demand in its tobacco and liquor businesses. Analysts are mostly neutral on the outlook for the shares, but they do all agree that there will be some level of upside ahead. The average target price of $3.44 implies a potential 23% upside over the next 12 months, at the time of writing. 

The post These 4 ASX 200 shares have slumped to fresh 52-week lows: Buy, sell or hold? appeared first on The Motley Fool Australia.

More reading

• How much could a $50,000 ASX share portfolio pay in dividends?
• Nervous investors turn to ASX 200 defensives as global energy shock drags on
• 100,720 shares of this high-yield ASX dividend stock pay income equal to the Age Pension
• Almost ready to retire? I’d buy cheap ASX dividend shares for passive income
• Down 40%: These high-yield ASX dividend shares are rated as buys

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Harvey Norman. The Motley Fool Australia has recommended Ansell. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) healthcare shares are down 1.1% on Tuesday and down 36% over the past 12 months.

The healthcare sector continues to battle significant headwinds, including a weaker US dollar, US tariffs, and higher labour costs.

Experts say the sector rout provides an opportunity to pick up high-quality ASX healthcare shares at a good price.

On The Bull this week, three experts explain their buy ratings on three ASX healthcare shares.

Sigma Healthcare Ltd (ASX: SIG) 

The Sigma Healthcare share price is $2.75, down 0.9% today and down 11% over the past six months.

Sigma Healthcare shares hit a record $3.28 apiece in June 2025 after the completion of the Chemist Warehouse merger in February.

The ASX healthcare has tumbled 16% from its historical peak, and Morgans analyst Damien Nguyen says it’s now a buy.

He explains why:

SIG is a leading wholesale distributor and retail pharmacy franchisor with operations in Australia, New Zealand, Ireland and the United Arab Emirates.

It has a solid balance sheet with conservative leverage and strong operating cash flows.

We believe SIG can continue to widen margins through expanding labels it owns and exclusive products.

We expect improving operating leverage through efficiencies in the supply chain and consolidation in distribution centres.

A softer share price provides a compelling buying opportunity for long term focused investors.

Polynovo Ltd (ASX: PNV) 

The Polynovo share price is steady at $1 on Tuesday, but the stock has lost 29% of its value over the past six months.

Polynovo shares are well off their 52-week high of $1.72 set in May last year.

Stuart Bromley from Medallion Financial Group has a buy rating on this ASX healthcare share. 

Bromley said: 

The company provides dermal regeneration solutions via its NovoSorb biodegradable polymer technology.

The company’s skin repair product continues to grow revenues. Group sales of NovoSorb were up 26 per cent in the first half of fiscal year 2026 when compared to the prior corresponding period. US sales were up 25.3 per cent.

The company has the capacity and product offerings to comfortably meet growing demand.

Pro Medicus Ltd (ASX: PME)

The Pro Medicus share price is $138.01, down 0.8% today and down 51% over the past six months.

Pro Medicus designs and distributes medical imaging software and services to healthcare providers around the world.

The Pro Medicus share price hit a record of $336 last July following an extraordinary two-year run.

The ASX healthcare share has since fallen by almost 60%, prompting a buy rating from Bromley.

He said: 

The share price is down significantly in the past year on fears of artificial intelligence impacting the business.

But the company continues winning large and long term contracts. PME recently renewed a five-year, $37 million contract with Northwestern Medicine based in Chicago. The renewal comes with increased minimums and a higher fee per transaction.

In our view, PME presents a rare chance to buy a world class software play at a significant discount.

The post 3 ASX healthcare shares to buy amid sector rout: experts appeared first on The Motley Fool Australia.

More reading

• 3 reasons to buy Pro Medicus shares today
• Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares
• These ASX 200 shares could rise 25% to 70%
• Why I think these high-quality ASX shares deserve a spot in most investment portfolios
• Which beaten down ASX healthcare stock is a better buy right now: Pro Medicus vs Cochlear shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended PolyNovo. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended PolyNovo and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX bank shares have slid over the last week along with the broader S&P/ASX 200 Index (ASX: XJO). 

Over the last five days, Australia’s benchmark index has fallen 2%. 

Similarly for big four bank shares: 

• Commonwealth Bank of Australia (ASX: CBA) is down 3.24%
• National Australia Bank Ltd (ASX: NAB) has fallen 1.9%
• ANZ Group Holdings Ltd (ASX: ANZ) is down 2.6%
• Westpac Banking Corp (ASX: WBC) is only down 0.8%. 

The big four banks dominate the Australian market, with more than 75% market share.

This makes them very attractive to many investors, who often see a decline of just 3-5% as an opportunity to increase their position.

Investors target these blue-chip holdings for steady growth and consistent dividends, rather than sudden, exponential growth.

With that in mind, let’s see if recent share price weakness makes these bank shares worth scooping up. 

Morgans bearish on the big four bank shares

The Motley Fool’s James Mickleboro reported last week that the team at Morgans sees more downside in the short term for these ASX bank shares. 

At the time of writing, it has the following price targets on each of these shares: 

• A sell rating and $124.26 price target on CBA shares – indicating a 28% downside
• A sell rating and $34.56 price target on NAB shares – suggesting a 14% drop
• A sell rating with a $34.06 price target on Westpac shares – indicating a 12% decline. 
• A sell rating and $30.72 price target on ANZ shares – a downside of just over 14% from current levels. 

What are other brokers saying?

Amongst the big four banks, sentiment appears to be the most negative towards CBA shares. 

In the past week, Catapult Wealth’s Dylan Evans said now could be an opportune time for investors to take profits (courtesy of The Bull).

Similarly, Damien Nguyen from Morgans also placed a sell rating on the market’s biggest company.

On the flip side, ANZ is still generating some positive views from brokers. 

Of the 14 analysts forecasting this big four bank via TradingView, the highest price target of $43 per share indicates a 19% upside. 

What about dividends?

For those investors more focussed on passive income rather than capital growth, ASX bank shares remain a viable option. 

Westpac paid a total of $1.54 per share last financial year. 

This equates to a dividend yield of approximately 3.85%. This is forecast to increase to $1.605 per share in FY26, and again to $1.64 per share in FY27.

Similarly, ANZ shares are currently trading on a partly franked trailing dividend yield of 4.4%.

The post Which of the big four bank shares has the most upside? appeared first on The Motley Fool Australia.

More reading

• Experts name 1 ASX bank share to buy and 2 to sell       
• $5,000 invested in NAB shares 6 months ago is now worth…
• Buy, hold, sell: Macquarie, Boss Energy, CBA shares
• Buy, hold, sell: Goodman Group, BHP, Westpac shares
• Experts name 3 ASX 200 shares to sell now

Motley Fool contributor Aaron Bell has positions in National Australia Bank. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is having a poor session on Tuesday. In afternoon trade, the benchmark index is down 0.55% to 8,719.9 points.

Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping:

Beach Energy Ltd (ASX: BPT)

The Beach Energy share price is down 2% to $1.17. Investors have been selling the energy company’s shares following the release of a disappointing third-quarter update. Beach Energy reported production of 4.8 MMboe for the quarter, which was up 7% on the prior quarter. However, it has downgraded its full year production guidance and now expects FY 2026 production to be in the range of 19.4 MMboe to 20.3 MMboe. This is down from its previous guidance range of 19.7 MMboe to 22.0 MMboe. This reflects a combination of factors, including weather-related disruptions, ramp-up challenges at the Waitsia Gas Plant, and cyclone-related shutdowns.

Domino’s Pizza Enterprises Ltd (ASX: DMP)

The Domino’s share price is down 10% to $15.96. The catalyst for this has been the release of an update from Domino’s Pizza Inc (NASDAQ: DPZ) in the United States overnight. It revealed same-store sales growth of just 0.9%, which was lower than the 2.3% increase the market was expecting. It also lowered its guidance for the full year. Investors may believe Domino’s Pizza Enterprises could also be struggling in the current environment.

Origin Energy Ltd (ASX: ORG)

The Origin Energy share price is down a further 4% to $11.60. Investors have been selling the energy giant’s shares this week after it released its quarterly report. Origin revealed that March quarter production was lower compared to the prior quarter. It also advised that Integrated Gas revenue was down $247 million compared to the prior quarter at $1,855 million. This reflects lower realised LNG prices. Origin Energy’s CEO, Frank Calabria, said: “Global commodity markets have experienced significant volatility this quarter, with the conflict in the Middle East affecting oil and LNG supply. Changes in oil prices have a lagged effect on Australia Pacific LNG’s long term export contracts, and we do not expect this to flow through to results until FY27.”

Pantoro Gold Ltd (ASX: PNR)

The Pantoro Gold share price is down 10% to $3.44. This follows the release of the gold miner’s quarterly update. Pantoro Gold revealed production of 17,757 ounces of gold, which is down 19.5% quarter on quarter. Also going the wrong way was its all-in sustaining cost, which increased 24.5% to $3,204 per ounce.

The post Why Beach Energy, Domino’s, Origin Energy, and Pantoro Gold shares are dropping today appeared first on The Motley Fool Australia.

More reading

• Origin Energy shares slump 10% this week: Buy, sell or hold?
• Why are Bega Cheese and Dominos shares crashing today?
• Why is everyone talking about Whitehaven, Deep Yellow and Beach Energy shares on Tuesday?
• Why is this $1.5 billion ASX 200 gold stock tumbling 8% today?
• Why are Beach Energy shares sinking today?

Motley Fool contributor James Mickleboro has positions in Domino’s Pizza Enterprises. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Domino’s Pizza and Domino’s Pizza Enterprises. The Motley Fool Australia has recommended Domino’s Pizza Enterprises. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is under pressure again on Tuesday, with the benchmark slipping deeper into a short-term slide.

At the time of writing, the ASX 200 is down 0.53% to 8,720 points. That puts the index at a 3-week low and extends a run of recent losses.

The move comes despite a relatively steady lead from the United States, where major indices have been holding near record levels.

Here’s what is behind the latest drop.

Broad weakness across the market

Selling has been fairly widespread today, with most sectors sitting in the red.

Earlier reports showed around three quarters of the ASX 200 trading lower at one point in the session. That lines up with the current price action, with few clear pockets of strength.

The S&P/ASX 200 Financials Index (ASX: XFJ) and S&P/ASX 200 Materials Index (ASX: XMJ) are both softer, down 0.1% and 0.84% respectively. Given their heavy weighting in the index, this tends to hold the ASX 200 back.

Some of the major banks are mixed, while large miners like BHP Group Ltd (ASX: BHP) and Rio Tinto Ltd (ASX: RIO) are edging lower.

The S&P/ASX 200 Health Care Index (ASX: XHJ) is also weaker, down 1.23%, adding to the broader drag on the index.

There are still a few standouts moving higher, but they are not large enough to offset the broader decline.

Oil and macro signals back in focus

One of the key factors sitting over the market right now is oil prices.

Brent crude has pushed higher in recent sessions, trading around the US$109 per barrel mark after a sharp rebound earlier in the week.

That move has been linked to renewed tension in the Middle East, particularly around stalled negotiations involving Iran.

Higher oil prices usually feed into inflation, which is where the market starts to pay closer attention.

Investors are already looking ahead to the next round of inflation data, which could shape expectations around interest rates.

There is also a Reserve Bank (RBA) meeting on the horizon, adding another layer of uncertainty for markets in the near term.

A run of losses starting to build

Today’s decline also adds to a string of recent falls for the ASX 200.

The index is now tracking towards its longest losing streak since mid-2022, which highlights how sentiment has shifted over the past week.

While the moves each day have not been extreme, the consistency of the selling is starting to stand out.

Trading volumes have also been relatively light, which can sometimes amplify short-term moves on the market.

What to watch from here

From here, attention is likely to stay on the macro signals.

Inflation data, which is due tomorrow morning, will be a key input, along with any shifts in oil prices or geopolitical headlines.

The other piece is whether buying interest starts to return at these levels, or if the ASX continues to drift lower in the short term.

The post ASX 200 falls to a fresh 3-week low. Here’s what’s driving the sell-off today appeared first on The Motley Fool Australia.

More reading

• This ASX gold stock just smashed records, so why is it down?
• Greatland Resources posts record March quarter cash build and gold-copper resource growth
• Beach Energy lifts production in Q3 FY26, updates outlook
• Reliance Worldwide resets FY26 outlook, updates on tariffs and Middle East
• Capricorn Metals reports Mt Gibson gold results

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Origin Energy Ltd (ASX: ORG) shares have slumped another 5% in Tuesday lunchtime trade, to $11.52 a piece.

Today’s decline means the shares have now tumbled nearly 10% since the ASX closed on Friday afternoon. 

For the year-to-date, Origin Energy shares are up nearly 2%, and they’re 10% higher than they were 12 months ago.

Why is everyone selling Origin Energy shares this week?

Origin Energy was one of the strongest performers on the S&P/ASX 200 Index (ASX: XJO) last week. But after the energy provider posted a March quarter update ahead of the ASX open on Monday morning, investors quickly sold off their shares.

The update, which covers Origin Energy’s Integrated Gas, Energy markets and Octopus energy segments, revealed declines across the board.

Its Integrated Gas segment saw lower production over the quarter, primarily reflecting two fewer days in the period, and natural field decline. The segment’s revenue was also down $247 million, on the back of lower realised LNG prices and the Australian dollar’s appreciation against the US dollar.

Its Energy Markets segment saw a 4% increase in sales volumes quarter-on-quarter, but a 32% decline in gas volumes, primarily due to lower trading volumes and lower gas demand for power generation.

Origin Energy’s share of Octopus Energy Group FY26 EBITDA has also been downgraded to between -$70 million and +$30 million. Guidance was previously in the $0-150 million range. Origin said emerging impacts from changes to the Energy Company Obligation scheme, higher gas capacity charges, and adverse weather in the UK in February and March have caused the guidance downgrade.

Origin Energy’s CEO, Frank Calabria, said:

Global commodity markets have experienced significant volatility this quarter, with the conflict in the Middle East affecting oil and LNG supply. Changes in oil prices have a lagged effect on Australia Pacific LNG’s long-term export contracts, and we do not expect this to flow through to results until FY27.

Are the shares still a buy? Or is there more downside ahead?

Data shows that brokers are neutral about Origin Energy shares. 

At the time of writing, TradingView data shows that three out of 10 analysts have a hold rating on the ASX energy stock. Another three have a sell or strong sell rating, and the final four have a buy or strong buy rating.

The average target price is $12.58, which implies a potential 8% upside at the time of writing. But some think the shares could drop 5% to $11.07, and others are more bullish and expect the energy provider’s shares could jump 21% higher to $14.10 a piece.

With lower EBITDA expected this year and the potential for oil and LNG headwinds to continue trickling through into FY27, I expect we could see some more downside ahead for Origin Energy shares this year. 

The post Origin Energy shares slump 10% this week: Buy, sell or hold? appeared first on The Motley Fool Australia.

More reading

• Why Beach Energy, Domino’s, Origin Energy, and Pantoro Gold shares are dropping today
• Why Cochlear, Karoon Energy, Origin Energy, and WiseTech shares are falling today
• Why are Origin Energy shares sinking on Monday?
• Here are the top 10 ASX 200 shares today
• Origin Energy shares: Experts argue the case to buy, hold, and sell

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Pro Medicus Ltd (ASX: PME) shares are slipping today.

Shares in the S&P/ASX 200 Index (ASX: XJO) health imaging company closed yesterday trading for $138.12. In early afternoon trade on Tuesday, shares are swapping hands for $137.07 each, down 0.8%.

For some context, the ASX 200 is down 0.5% at this same time.

As you’re likely aware, Pro Medicus shares have come under heavy pressure since last July.

Indeed, on 17 July the stock notched an all-time closing high of $330.48 a share. The share price has since crashed 58.5% from that high water mark.

But it’s not just Pro Medicus that has suffered.

While the ASX 200 is up 0.8% since 17 July, the S&P/ASX All Technology Index (ASX: XTX) has tumbled 32.4% over this period as investors sold off a lot of Software as a Service (SaaS) stocks.

In what you may have heard called the SaaSpocalypse, Pro Medicus and many other stocks dependent on their proprietary software have gotten hit amid investors’ concerns that artificial intelligence, or AI, might replace the services these companies provide.

But following the past months’ steep selloff, Medallion Financial Group’s Stuart Bromley now sees “a rare buying opportunity” (courtesy of The Bull).

Should you buy Pro Medicus shares today?

“The company provides medical imaging software and services to hospitals and healthcare groups across the world,” Bromley said.

Citing the first reason he’s bullish on Pro Medicus shares, Bromley noted, “The share price is down significantly in the past year on fears of artificial intelligence impacting the business.”

But that sell-off doesn’t reflect the ASX 200 healthcare stock’s ongoing contract wins. Which is the second reason you might want to buy the stock today.

According to Bromley:

The company continues winning large and long-term contracts. PME recently renewed a five-year, $37 million contract with Northwestern Medicine based in Chicago. The renewal comes with increased minimums and a higher fee per transaction.

Pro Medicus announced that $37 million contract renewal on 13 April.

Commenting on the deal on the day, Pro Medicus CEO Sam Hupert said:

We are extremely pleased that in addition to committing to a second five-year term at an increased fee per exam, Northwestern Medicine have also committed to an increase in their minimums reflecting the growth in their exam volumes since standardising on our platform five years ago.

Summing up his buy recommendation on Pro Medicus shares, Medallion Financial Group’s Bromley concluded, “In our view, PME presents a rare chance to buy a world class software play at a significant discount.”

The post 3 reasons to buy Pro Medicus shares today appeared first on The Motley Fool Australia.

More reading

• These ASX 200 shares could rise 25% to 70%
• Which beaten down ASX healthcare stock is a better buy right now: Pro Medicus vs Cochlear shares
• Buy, hold, sell: Pro Medicus, Life360, A2 Milk shares
• Analysts pick 3 ASX 200 stocks to buy
• Top brokers name 3 ASX shares to buy next week

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX gold stock Greatland Resources Ltd (ASX: GGP) is edging lower today. During Tuesday lunch hour trade, it was down 2.1% to $13.87, even after the company delivered a standout quarterly result.

The gold and copper miner reported a record $260 million cash build for the March quarter, driven by strong production and solid operations. That pushed its closing cash balance to an impressive $1.2 billion.

Despite today’s dip, the $9 billion ASX gold stock is still up 42% over the past month, comfortably beating the roughly 2% gain from the S&P/ASX 200 Index (ASX: XJO).

So, what’s behind the pullback?

A strong quarter on all fronts

Greatland didn’t just perform well; the ASX gold stock delivered across the board.

The company produced 82,723 ounces of gold and 4,128 tonnes of copper during the quarter, keeping all-in sustaining costs (AISC) tight at $2,056 per ounce. It then converted that production into strong sales, moving 97,800 ounces of gold and 4,620 tonnes of copper, generating $742 million in revenue.

Cash flow followed suit. Operations delivered $453 million, lifting total cash to $1,208 million, up sharply from $948 million previously. In short: more metal, more revenue, more cash.

And it’s not slowing down

Management expects full-year gold production to land near — or even above — the top end of guidance. Costs, meanwhile, are tracking toward the lower end of forecasts.

Greatland Managing Director, Shaun Day, commented:

Based on the strong year-to-date performance, we currently expect full-year production to be around, or slightly above, the upper end of the guidance range of 260,000 – 310,000 ounces, and full-year AISC to trend towards the lower end of the guidance range of $2,400 – $2,800 per ounce.

The balance sheet remains a standout. The ASX gold stock carries no debt and sits on total liquidity of $1.28 billion, including an undrawn $75 million facility.

It also retains full exposure to rising gold prices while using put options to soften potential near-term downside.

Growth engine building momentum

Operationally, the company is pushing ahead with its key growth projects.

At Havieron, development is advancing, with permitting progressing and early decline works already underway — steps that help de-risk future production. Meanwhile, resource upgrades at Telfer and O’Callaghans have boosted total group resources to 14.9 million ounces of gold and 645,000 tonnes of copper.

That strengthens the long-term outlook and supports ambitions for a multi-decade mining footprint in the Paterson region.

Drilling is also ramping up, with a massive 240,000-metre program on track this financial year.

So why the drop?

After a 42% surge in just one month, today’s decline of the ASX gold stock looks less like bad news — and more like a breather. Investors may simply be locking in gains following a strong run, even as the underlying business continues to deliver.

Greatland has just posted a powerful quarter, with rising production, surging cash flow, and a rock-solid balance sheet. But when a stock runs this hard, this fast, even good news can trigger a pause.

For long-term investors, the key question isn’t today’s dip. It’s whether the company can keep turning strong operations into sustained growth.

The post This ASX gold stock just smashed records, so why is it down? appeared first on The Motley Fool Australia.

More reading

• ASX 200 falls to a fresh 3-week low. Here’s what’s driving the sell-off today
• Greatland Resources posts record March quarter cash build and gold-copper resource growth
• Beach Energy lifts production in Q3 FY26, updates outlook
• Reliance Worldwide resets FY26 outlook, updates on tariffs and Middle East
• Capricorn Metals reports Mt Gibson gold results

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.5% to 8,725.3 points on Tuesday.

Among the 11 market sectors, energy is on its own in the green, up 0.3%, after the Brent Crude oil price rose to US$108 per barrel.

Utilities is the worst performer today, down 3.6%.

ASX 200 consumer discretionary shares are also down 1.2% ahead of tomorrow’s crucial quarterly inflation report.

Meanwhile, on The Bull this week, two experts give us their views on three ASX 200 shares.

Let’s take a look.

Sigma Healthcare Ltd (ASX: SIG) 

The Sigma Healthcare share price is $2.76, down 0.5% on Tuesday and down 11% over the past six months.

Sigma Healthcare shares hit a record of $3.28 apiece in June 2025 before enduring a prolonged tumble alongside the broader sector.

Damien Nguyen from Morgans has a buy rating on this ASX 200 healthcare share. 

He explains why:

It has a solid balance sheet with conservative leverage and strong operating cash flows.

We believe SIG can continue to widen margins through expanding labels it owns and exclusive products.

We expect improving operating leverage through efficiencies in the supply chain and consolidation in distribution centres.

A softer share price provides a compelling buying opportunity for long term focused investors.

Macquarie Group Ltd (ASX: MQG)

The Macquarie share price is $231.15, down 0.4% today and up 16% over the past month.

Nguyen has a hold rating on this ASX 200 bank share.

He says:

Macquarie is a diversified financial services group with strengths across asset management, infrastructure and global markets. Its business model benefits from long term infrastructure investment and energy transition themes, but earnings can be volatile due to market conditions.

Recent performance has been solid, and much of the medium term opportunity is already reflected in the share price, in our view. While Macquarie remains a high quality company with strong management, near term upside looks balanced by cyclical and market risks. At current levels, a hold is appropriate.

Macquarie will release its full-year FY26 results next Friday, 8 May.

Santos Ltd (ASX: STO)

The Santos share price is $7.73, up 1% today and up 26% in the year to date (YTD).

Most of that YTD gain has been due to skyrocketing oil and gas prices as the Iran war continues into its ninth week.

Stuart Bromley from Medallion Financial Group has a sell rating on this global energy giant.

We would be inclined to lock in gains given volatile and uncertain energy prices emanating from the conflict in the Middle East.

Bromley points out that Santos shares have risen from $5.92 on 7 January to $7.73 today.

For full-year FY25, Santos reported an 8% fall in revenue due to lower realised prices and a 33% drop in net profit after tax (NPAT).

The post Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Macquarie, Boss Energy, CBA shares
• 5 things to watch on the ASX 200 on Tuesday
• Why I think these high-quality ASX shares deserve a spot in most investment portfolios
• Experts name 3 ASX 200 shares to sell now
• Analysts pick 3 ASX 200 stocks to buy

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX rare earths stock Oceana Metals Ltd (ASX: OCN) is off to the races on Tuesday.

If you haven’t seen Oceana Metals shares on the boards lately, that’s because the stock entered a trading halt on 13 February pending an announcement about a proposed acquisition.

That announcement has been a long time coming!

But today the ASX rare earths stock is back in action after releasing the long-awaited acquisition news.

And investors are responding very enthusiastically.

On 12 February, Oceana Metals shares closed at 43.5 cents. In earlier trade today, shares were trading for 73.0 cents apiece, up a whopping 67.8%. After some likely profit taking, shares are currently trading for 60.5 cents each, up 39.1%.

For some context, the All Ordinaries Index (ASX: XAO) is down 0.5% at this same time.

Here’s what we know.

ASX rare earths stock rockets on Brazil mine purchase

Oceana Metals shares are surging today after the miner reported that it has entered into a binding agreement with private vendors to acquire 100% of the Serra Negra rare earths and niobium project, located in Brazil.

The ASX rare earths stock said it will acquire the project by purchasing Songeo Mineracao, the company holding the Serra Negra permits. On completion, this will provide Oceans with full ownership and control, enabling it to advance the project through resource definition and development studies.

According to the release, Serra Negra, a 10-kilometre-wide carbonatite complex. This makes it the largest known alkaline carbonatite intrusion in the Alto Paranaiba Igneous Province.

Oceana said it will pay a total upfront and deferred consideration of up to US$10.3 million in cash and shares for the rare earths project, as well as a trailing 2.5% net smelter royalty.

The ASX rare earths stock noted that it has received “firm commitments” for a $20 million share placement, anchored by domestic and international institutional, professional and sophisticated investors. Oceana plans to use the new funds for the Serra Negra acquisition and an accelerated exploration program.

What did Oceana Metals management say?

“This is an outstanding opportunity to acquire a global-scale rare earths and niobium project in a tier-one location,” Oceana Managing Director, Mick Wilson said. “The Serra Negra Project will transform Oceana and give our shareholders exposure to a critical minerals project with huge scope for growth.”

Looking to what’s next for the ASX rare earths stock, Wilson added:

Our recent due diligence and site visit confirmed a large quantity of historic core remains available for re-assay (around 8,000 metres) and our technical team has already made preparations to do this.

At the same time, we are planning surveys of modern geophysics, and plan to commence an accelerated 20,000 metre drill program, in what will be the first drilling program at Serra Negra in well over a decade.

The post Guess which ASX rare earths stock just leapt 68% on big acquisition news appeared first on The Motley Fool Australia.

More reading

• Why Beach Energy, Domino’s, Origin Energy, and Pantoro Gold shares are dropping today
• ASX 200 falls to a fresh 3-week low. Here’s what’s driving the sell-off today
• Origin Energy shares slump 10% this week: Buy, sell or hold?
• 3 reasons to buy Pro Medicus shares today
• This ASX gold stock just smashed records, so why is it down?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.